Objective: To evaluate a-linolenic acid (ALA) (18X3 n-3) and linolenic acid (LA) (18X2 n-6) in cholesterol esters (CE) as markers of ALA and LA dietary intakes in preterm infants. Subjects: Forty-®ve preterm infants: two groups fed different formulas, the third fed human milk. Design: ALA and LA dietary intakes were precisely recorded in each infant to accurately determine the cumulative amount of ingested ALA and LA during two intervals: (i) between the second day after the ®rst signi®cant formula intake (D0) and the ®fteenth day (D15); and (ii) between D0 and the ®rst day of the 37th week of post-conception age (W37). The corresponding amounts of ingested ALA and LA were related to ALA and LA levels determined by capillary column gas ± liquid chromatography in plasma cholesterol esters at D15 and W37, respectively. Results: ALA in CE was very signi®cantly correlated to D0 ± D15 and D0 ± W37 ALA intakes (0.66; P 0.0001 and 0.70; P 0.0001), respectively. LA in CE was weakly correlated to D0 ± D15 LA intakes (0.03; P 0.01) and whatever the group (human milk or enriched formula) the correlation was lost at W37. Conclusion: In preterm infants, ALA in CE can be considered as representative of ALA dietary intakes, whereas LA in CE appears as a poor marker of LA intakes. Descriptors: a-linolenic acid; linoleic acid; dietary intake; cholesterol esters; preterm infant
Introduction
There is growing interest in the dietary supply of alinolenic acid (ALA) not only as the essential precursor of the n-3 series of polyunsaturated fatty acids (PUFAs) but also as possible contributor to the prevention of some cardiovascular diseases (Leaf, 1999) . A randomized trial reported the bene®cial effect of a Mediterranean diet enriched with ALA for the reduction of the risk of secondary coronary disease (de Lorgeril et al, 1999) and two recent studies have reported that ALA dietary intake and ALA in adipose tissue were associated with a decrease in the risk of fatal ischemic heart disease and of myocardial infarction respectively (Guallar et al, 1999; Hu et al, 1999) .
There are serious dif®culties evaluating dietary intakes in epidemiological or interventional studies: chemical analysis of meals is necessarily restricted to a limited number of samples that are not always representative of the whole. Most evaluations of dietary intakes in large cohorts are based on diet recording for a few days (Posner et al, 1992) or nutritional surveys of diet history covering several months (Jain et al, 1980) . Unfortunately, polyunsaturated fatty acid intake and especially LA and ALA cannot be analyzed from such dietary investigations since individual values for these fatty acids are generally lacking in the tables available at the present time (Paul & Southgate, 1978; Feinberg et al, 1991) .
Given these dif®culties, biological markers of ALA dietary supply might be very useful and it was recently noted that information on ALA intakes is still lacking (Voskuil et al, 1996) . The percentages of some PUFAs in CE were reported to be representative for their oral intake (Glatz et al, 1989) , but there is no consensus in the literature as far as ALA is concerned.
In two recent interventional studies of premature newborns (Billeaud et al, 1997; Rodriguez et al, personal communication) the dietary supply of LA and ALA was completely and precisely controlled and adjusted to the body weight of the babies. This dietary control allowed us to investigate in the present study whether ALA in plasma cholesterol esters (CE) can be considered as a valuable marker of the dietary intake of this acid in newborns.
Methods

Subjects
Preterm infants (gestional age less than 34 weeks, n 45) were enrolled for preterm infant formula supplementation which was approved by the Montpellier Hospital ethic committee. None had metabolic disorders or congenital malformations and clinical conditions permitted early oral feeding. From this population 30 infants whose mothers had elected not to breast-feed were randomly assigned either to the group receiving a high ALA formula (HLF, n 20), or to the group receiving a low ALA formula (LLF, n 10). In HLF group, gestional age (mean AE s.d.) was 32.4 AE 1.5 weeks and birth weight range was 1300 ± 2200 g. In the LLF group gestational age and birth weight range were 32.3 AE 1.4 weeks, and 1270 ± 2220 g, respectively. In the infants fed human milk (HM group: n 15) gestational age and birth weight range were 31.2 AE 1.7 weeks and 1090 ± 2290 g, respectively. For ethical reasons the group fed human milk was not randomized but was constituted of those mothers who chose to breastfeed. Six infants had dropped out of the study at W37 and some samples were lacking for technical reasons, which explains the difference in Tables 1 and 2 .
Study design
In the high ALA formula enriched with LEAR oil (low erucic acid rapeseed oil) ALA accounted for 1.95% of total fatty acids (0.77% of total energy). In the low ALA formula, ALA accounted for 0.55% of total fatty acids (0.22% of total energy). Except for ALA level, HLF and LLF were identical for each nutrient.
At birth, infants received either fat-free total parenteral or mixed nutrition. Oral intake was increased progressively to reach a total amount of 180 mlakgaday (140 kcalakga day). D0 and D15 corresponded to the second and ®fteenth day after the ®rst signi®cant formula intake (de®ned as D0); at D15 complete oral intake (180 mLakgaday) had been established for one week. The end of the study corresponded to the discharge of the infants at exactly the 37th week of post-conception age (W37). Mean durations of 15.6 and 16.2 days elapsed between D15 and W37 in LLF and HLF, respectively, resulting in 30.6 and 31.2 days of enteral feeding (D0 to W37 interval).
Complete day-by-day dietary intakes were recorded between D0 and D15 and between D0 and W37. From the volume of milk ingested the total amount of LA ingested by 45 infants (whole cohort: HLF LLF HM) between D0 and D15 was calculated. The same was done for 38 infants for the period D0 ± 37W. The same protocol was used for ALA but data was recorded for 44 and 37 newborns, respectively, for the D0 ± D15 and D0 ± W37 periods (data from one newborn was lacking for ALA analysis).
Analytical methods
At D15 and W37, fatty acid analysis of plasma cholesterol esters was performed by capillary column gas liquid chromatography as previously described (Billeaud et al, 1997) . The values were expressed as percentage (WtaWt) of all the length range of 15 ± 24 carbon atoms and traces of unknown products.
Statistical analysis
The total amounts of ALA and LA ingested by the infants between D0 and D15 and between D0 and 37W were correlated to the ALA and LA percentages in the plasma CE fraction at D15 and W37, respectively. The relationships between ALA and LA intakes and the percentages of ALA and LA in plasma CE were investigated as linear correlations and tested by the Pearson correlation coef®-cient. A P value lower than 0.05 was considered as signi®cant. Data from the LLF group were included in the whole cohort, but this group was too small (n 10) to be submitted to individual statistical analysis.
Results
The mean values of the total amount of ALA ingested by the premature infants between D0 and D15 and W37 are shown in Table 1 . There was a wide range of ALA intakes in both the D0 ± D15 and D0 ± W37 periods. There was also a wide range of ALA levels in CE at both D15 and W37. The Pearson correlation coef®cient calculated between the ALA levels in CE at D15 and the ALA intakes during the period D0 ± D15 (0.663) was highly signi®cant (P 0.0001). The correlation was also high between the ALA levels in CE at W37 and the ALA intake during the period D0 ± W37 (0.70, P 0.0001).
This data from precise ALA dietary intake measurements clearly shows that ALA in CE can be considered as a biomarker of ALA intake at least during the neonatal period. Moreover, the data being normally distributed the information available from ALA in CE remains valuable in the extreme part of the distribution.
Concerning LA, a lower correlation was observed between LA in CE at D15 and D0-D15 LA intakes (0.367, P 0.01) ( Table 2 ). The correlation was lost between LA in CE at W37 and the D0-W37 LA intakes. The same ®ndings were noted when the group receiving LA-enriched formula was considered separately (Table 2 ). In the group receiving human milk, there was no correlation at all either at D15 or W37.
Discussion
No consensus exists in the literature regarding the possible relationships between dietary ALA and the percentage of this acid in CE. In a study of 118 mildly hypercholesterolemic patients aged 23 ± 58 y who received various amounts of ALA supplied by LEAR oil (low erucic acid rapeseed oil) over 6 months, the percentage of ALA in (CE) was found signi®cantly higher in the groups receiving higher oral intake of this acid (Sarkkinen et al, 1994) . Based on these data, it was proposed that ALA percentage in CE could be considered as an indicator of subject compliance. Another interventional study in 10 healthy men aged 21 ± 37 y reported higher ALA percentages in (Kelley et al, 1993) . Unfortunately, in this study, fatty acid analysis was only conducted in total serum but not in CE fraction. On the other hand, Sandker et al (1993) , referring to cohorts from the Seven Countries Study, observed higher levels of ALA in CE in Cretan men (Greece) compared with Zutphen men (Netherlands), whereas the dietary content of ALA was higher in the diet of the Zutphen men. In elderly people, Voskuil et al (1996) did not ®nd any correlation between ALA dietary intake and the same acid in CE (r À0.14).
Our data con®rm the observation of Saarkinen et al (1994) and Kelley et al (1993) but disagree with those of Sandker et al (1993) and Voskuil et al (1996) . Differences in chromatographic analysis in ALA intake evaluation or, in subject diets and ages may have contributed to this discrepancy. As suggested by Voskuil et al (1996) , it is possible that the packed columns used in these two studies were not adequate for ALA determination in cholesterol esters. Moreover it should be noted that the LAaALA ratio in the study of elderly Zutphen men ranged between 11 and 12.5. In the premature newborns of our study, this ratio was adjusted to 6, a ratio that has been shown to preserve the balance between the n-6 and n-3 pathways in infants (Gibson et al, 1994) and adults (Lasserre et al, 1985) . Most of the data of previous studies were obtained after dietary intake evaluation by dietary survey, using tables and some analysis of dietary samples.
Previous studies of plasma ALA or LA as biomarkers of dietary intakes did not use a controlled diet. In the present study, we evaluated the exact amount of ALA and LA in a cohort of preterm infants over two periods D0 ± D15 and D0 ± W37, and correlated these values with ALA levels in CE at the end of each period: D15 and W37. Both values of the ALA dietary intake and the ALA levels in CE were widely scattered. The correlation coef®cients 0.66 and 0.70 and the high signi®cance (P 0.0001) clearly indicate that the parameters were related. Thus, it appears that metabolic pathways and especially the substrate speci®city of lecithin cholesterol acyl transferase do not disrupt the strong relation linking ALA dietary intakes and the level of this acid in cholesterol esters. It is noteworthy that in LEAR oil, ALA is preferentially located in the sn-2 position of the triglycerides (66% vs 30% in soya-bean oil). In conclusion, the data strongly suggest that, at least in infants, ALA levels may be considered as indicative of ALA dietary intakes.
Concerning LA, several studies in adults have shown that linoleic acid in CE is strongly linked to the dietary intake of this acid and that either the linoleic acidaoleic acid ratio or LA itself in CE can be considered as a marker of subject adherence to dietary interventions (Moilanen et al, 1985; Glatz et al, 1989; Sarkkinen et al, 1994; Voskuil et al, 1996) . Our present data obtained in newborn do not con®rm this observation.
To investigate further why the correlation between LA intake and LA in CE was weak at D15 and lost at W37, we looked at the correlation in the subgroup fed LA-enriched formula and in the subgroup fed human milk. The data from the LLF group were not submitted to separate statistical analysis because n was only 10. Both the correlation and signi®cance were lost at W37 indicating that, whatever the group, there was no relationship between ingested LA and LA in CE at that time. In both groups, a few subjects dropped out of the study and n varied between D0 and W37 from n 20 to n 16 and from n 15 to n 14 in the HLF and HM groups, respectively. To investigate if these changes in¯uenced the data, the statistical analysis was repeated with only thoses subjects who completed the study at W37 (n 16 and 14 in HLF and HM, respectively) . No correlation or statistical signi®cance was noted (data not shown), demonstrating that the small variation in n was not responsible for the discrepancy observed between ALA and LA behavior. This discrepancy did not result from physical differences between the subjects since each pair of values, ALA intakes vs ALA in CE and LA intakes vs LA in CE were obtained from the same subject. Moreover, differences in birth weight, gestational age and health status were Alpha linolenic acid in dietary intakes F Babin et al extremely low between the HLF and HM groups. It is possible that the progressive accumulation of ALA could have competed with LA and thus impaired the bioavailability of this acid at the absorption step or at incorporation into CE. This hypothesis is unlikely, however, since the LAaALA ratio in the diet 6a1 largely favored LA. In addition, it is well known that LA is the most abundant fatty acid in CE and the best substrate for lecithin cholesterol acyl transferase. It appears that, in preterm infants, the lack of correlation between LA dietary intakes and LA in CE results from more complex nutritional and metabolic processes which remain to be determined.
